nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A4—type 2 diabetes mellitus	0.179	1	CbGaD
Boceprevir—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0415	0.114	CbGbCtD
Boceprevir—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.037	0.102	CbGbCtD
Boceprevir—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0312	0.0857	CbGbCtD
Boceprevir—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0268	0.0736	CbGbCtD
Boceprevir—CTSV—corneal epithelium—type 2 diabetes mellitus	0.025	0.236	CbGeAlD
Boceprevir—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0249	0.0684	CbGbCtD
Boceprevir—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0222	0.061	CbGbCtD
Boceprevir—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0203	0.0558	CbGbCtD
Boceprevir—CYP3A5—Losartan—type 2 diabetes mellitus	0.0192	0.0529	CbGbCtD
Boceprevir—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0184	0.0506	CbGbCtD
Boceprevir—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0177	0.0488	CbGbCtD
Boceprevir—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.016	0.0441	CbGbCtD
Boceprevir—CMA1—tunica intima—type 2 diabetes mellitus	0.0151	0.142	CbGeAlD
Boceprevir—ABCB1—Glyburide—type 2 diabetes mellitus	0.0137	0.0377	CbGbCtD
Boceprevir—ABCB1—Losartan—type 2 diabetes mellitus	0.0125	0.0345	CbGbCtD
Boceprevir—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0121	0.0334	CbGbCtD
Boceprevir—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0116	0.032	CbGbCtD
Boceprevir—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0116	0.032	CbGbCtD
Boceprevir—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.011	0.0303	CbGbCtD
Boceprevir—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00821	0.0226	CbGbCtD
Boceprevir—CYP3A4—Losartan—type 2 diabetes mellitus	0.00751	0.0206	CbGbCtD
Boceprevir—CTSK—leg—type 2 diabetes mellitus	0.00607	0.0574	CbGeAlD
Boceprevir—CTSK—hindlimb—type 2 diabetes mellitus	0.00542	0.0512	CbGeAlD
Boceprevir—CMA1—artery—type 2 diabetes mellitus	0.00516	0.0487	CbGeAlD
Boceprevir—CTSV—islet of Langerhans—type 2 diabetes mellitus	0.0026	0.0245	CbGeAlD
Boceprevir—CTSL—islet of Langerhans—type 2 diabetes mellitus	0.00212	0.02	CbGeAlD
Boceprevir—CTSV—nephron tubule—type 2 diabetes mellitus	0.00209	0.0198	CbGeAlD
Boceprevir—CTSV—kidney—type 2 diabetes mellitus	0.00184	0.0174	CbGeAlD
Boceprevir—CTSV—pancreas—type 2 diabetes mellitus	0.00182	0.0172	CbGeAlD
Boceprevir—CTSL—retina—type 2 diabetes mellitus	0.00181	0.0171	CbGeAlD
Boceprevir—CMA1—cardiovascular system—type 2 diabetes mellitus	0.00179	0.0169	CbGeAlD
Boceprevir—CTSV—cortex of kidney—type 2 diabetes mellitus	0.00179	0.0169	CbGeAlD
Boceprevir—CTSL—nephron tubule—type 2 diabetes mellitus	0.00171	0.0161	CbGeAlD
Boceprevir—CTSV—adipose tissue—type 2 diabetes mellitus	0.00166	0.0156	CbGeAlD
Boceprevir—CMA1—adipose tissue—type 2 diabetes mellitus	0.00158	0.0149	CbGeAlD
Boceprevir—CTSL—cardiovascular system—type 2 diabetes mellitus	0.00153	0.0145	CbGeAlD
Boceprevir—CTSL—kidney—type 2 diabetes mellitus	0.0015	0.0142	CbGeAlD
Boceprevir—CTSL—pancreas—type 2 diabetes mellitus	0.00149	0.0141	CbGeAlD
Boceprevir—CTSL—cortex of kidney—type 2 diabetes mellitus	0.00146	0.0138	CbGeAlD
Boceprevir—CTSS—islet of Langerhans—type 2 diabetes mellitus	0.0014	0.0132	CbGeAlD
Boceprevir—CTSK—retina—type 2 diabetes mellitus	0.00137	0.0129	CbGeAlD
Boceprevir—CTSL—adipose tissue—type 2 diabetes mellitus	0.00135	0.0128	CbGeAlD
Boceprevir—Telaprevir—CYP3A4—type 2 diabetes mellitus	0.00131	0.534	CrCbGaD
Boceprevir—CTSS—retina—type 2 diabetes mellitus	0.0012	0.0113	CbGeAlD
Boceprevir—CTSK—cardiovascular system—type 2 diabetes mellitus	0.00116	0.0109	CbGeAlD
Boceprevir—Telaprevir—ALB—type 2 diabetes mellitus	0.00114	0.466	CrCbGaD
Boceprevir—CTSK—kidney—type 2 diabetes mellitus	0.00113	0.0107	CbGeAlD
Boceprevir—CTSK—pancreas—type 2 diabetes mellitus	0.00112	0.0106	CbGeAlD
Boceprevir—CMA1—liver—type 2 diabetes mellitus	0.00111	0.0105	CbGeAlD
Boceprevir—CTSK—adipose tissue—type 2 diabetes mellitus	0.00102	0.00963	CbGeAlD
Boceprevir—CTSS—cardiovascular system—type 2 diabetes mellitus	0.00101	0.00957	CbGeAlD
Boceprevir—CTSS—kidney—type 2 diabetes mellitus	0.00099	0.00936	CbGeAlD
Boceprevir—CTSS—pancreas—type 2 diabetes mellitus	0.000984	0.0093	CbGeAlD
Boceprevir—CTSS—cortex of kidney—type 2 diabetes mellitus	0.000965	0.00912	CbGeAlD
Boceprevir—CTSL—liver—type 2 diabetes mellitus	0.000948	0.00896	CbGeAlD
Boceprevir—CTSS—adipose tissue—type 2 diabetes mellitus	0.000893	0.00844	CbGeAlD
Boceprevir—CTSK—liver—type 2 diabetes mellitus	0.000714	0.00675	CbGeAlD
Boceprevir—CTSS—liver—type 2 diabetes mellitus	0.000626	0.00592	CbGeAlD
Boceprevir—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000465	0.00439	CbGeAlD
Boceprevir—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000374	0.00354	CbGeAlD
Boceprevir—CYP3A5—kidney—type 2 diabetes mellitus	0.000329	0.00311	CbGeAlD
Boceprevir—CYP3A5—pancreas—type 2 diabetes mellitus	0.000327	0.00309	CbGeAlD
Boceprevir—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.00032	0.00303	CbGeAlD
Boceprevir—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000296	0.0028	CbGeAlD
Boceprevir—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000247	0.00233	CbGeAlD
Boceprevir—CYP3A4—kidney—type 2 diabetes mellitus	0.000247	0.00233	CbGeAlD
Boceprevir—ABCB1—retina—type 2 diabetes mellitus	0.000211	0.002	CbGeAlD
Boceprevir—CYP3A5—liver—type 2 diabetes mellitus	0.000208	0.00196	CbGeAlD
Boceprevir—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000199	0.00188	CbGeAlD
Boceprevir—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000179	0.00169	CbGeAlD
Boceprevir—ABCB1—kidney—type 2 diabetes mellitus	0.000175	0.00165	CbGeAlD
Boceprevir—ABCB1—pancreas—type 2 diabetes mellitus	0.000174	0.00164	CbGeAlD
Boceprevir—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.00017	0.00161	CbGeAlD
Boceprevir—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000157	0.00149	CbGeAlD
Boceprevir—CYP3A4—liver—type 2 diabetes mellitus	0.000156	0.00147	CbGeAlD
Boceprevir—ABCB1—liver—type 2 diabetes mellitus	0.00011	0.00104	CbGeAlD
Boceprevir—Hypertension—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000347	CcSEcCtD
Boceprevir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.62e-05	0.000346	CcSEcCtD
Boceprevir—Flushing—Ramipril—type 2 diabetes mellitus	7.61e-05	0.000346	CcSEcCtD
Boceprevir—Angioedema—Losartan—type 2 diabetes mellitus	7.61e-05	0.000346	CcSEcCtD
Boceprevir—Infection—Metformin—type 2 diabetes mellitus	7.6e-05	0.000345	CcSEcCtD
Boceprevir—Insomnia—Valsartan—type 2 diabetes mellitus	7.6e-05	0.000345	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.56e-05	0.000344	CcSEcCtD
Boceprevir—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.54e-05	0.000343	CcSEcCtD
Boceprevir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.53e-05	0.000342	CcSEcCtD
Boceprevir—Chest pain—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000342	CcSEcCtD
Boceprevir—Myalgia—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000342	CcSEcCtD
Boceprevir—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.53e-05	0.000342	CcSEcCtD
Boceprevir—Shock—Metformin—type 2 diabetes mellitus	7.53e-05	0.000342	CcSEcCtD
Boceprevir—Insomnia—Orlistat—type 2 diabetes mellitus	7.51e-05	0.000341	CcSEcCtD
Boceprevir—Malaise—Losartan—type 2 diabetes mellitus	7.51e-05	0.000341	CcSEcCtD
Boceprevir—Anxiety—Irbesartan—type 2 diabetes mellitus	7.5e-05	0.000341	CcSEcCtD
Boceprevir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	7.5e-05	0.000341	CcSEcCtD
Boceprevir—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.5e-05	0.000341	CcSEcCtD
Boceprevir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	7.49e-05	0.00034	CcSEcCtD
Boceprevir—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.49e-05	0.00034	CcSEcCtD
Boceprevir—Vertigo—Losartan—type 2 diabetes mellitus	7.48e-05	0.00034	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.00034	CcSEcCtD
Boceprevir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.48e-05	0.00034	CcSEcCtD
Boceprevir—Syncope—Losartan—type 2 diabetes mellitus	7.46e-05	0.000339	CcSEcCtD
Boceprevir—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.45e-05	0.000339	CcSEcCtD
Boceprevir—Leukopenia—Losartan—type 2 diabetes mellitus	7.45e-05	0.000339	CcSEcCtD
Boceprevir—Discomfort—Irbesartan—type 2 diabetes mellitus	7.44e-05	0.000338	CcSEcCtD
Boceprevir—Skin disorder—Metformin—type 2 diabetes mellitus	7.43e-05	0.000338	CcSEcCtD
Boceprevir—Immune system disorder—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000337	CcSEcCtD
Boceprevir—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.39e-05	0.000336	CcSEcCtD
Boceprevir—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.39e-05	0.000336	CcSEcCtD
Boceprevir—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.39e-05	0.000336	CcSEcCtD
Boceprevir—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.37e-05	0.000335	CcSEcCtD
Boceprevir—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000335	CcSEcCtD
Boceprevir—Palpitations—Losartan—type 2 diabetes mellitus	7.36e-05	0.000334	CcSEcCtD
Boceprevir—Nausea—Glimepiride—type 2 diabetes mellitus	7.33e-05	0.000333	CcSEcCtD
Boceprevir—Arrhythmia—Ramipril—type 2 diabetes mellitus	7.32e-05	0.000333	CcSEcCtD
Boceprevir—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.32e-05	0.000333	CcSEcCtD
Boceprevir—Nausea—Sitagliptin—type 2 diabetes mellitus	7.31e-05	0.000332	CcSEcCtD
Boceprevir—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.31e-05	0.000332	CcSEcCtD
Boceprevir—Asthenia—Glyburide—type 2 diabetes mellitus	7.31e-05	0.000332	CcSEcCtD
Boceprevir—Decreased appetite—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000332	CcSEcCtD
Boceprevir—Cough—Losartan—type 2 diabetes mellitus	7.26e-05	0.00033	CcSEcCtD
Boceprevir—Urticaria—Gliclazide—type 2 diabetes mellitus	7.26e-05	0.00033	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.25e-05	0.00033	CcSEcCtD
Boceprevir—Alopecia—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000329	CcSEcCtD
Boceprevir—Fatigue—Valsartan—type 2 diabetes mellitus	7.24e-05	0.000329	CcSEcCtD
Boceprevir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.23e-05	0.000329	CcSEcCtD
Boceprevir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	7.23e-05	0.000329	CcSEcCtD
Boceprevir—Decreased appetite—Orlistat—type 2 diabetes mellitus	7.22e-05	0.000328	CcSEcCtD
Boceprevir—Pruritus—Glyburide—type 2 diabetes mellitus	7.2e-05	0.000327	CcSEcCtD
Boceprevir—Mental disorder—Ramipril—type 2 diabetes mellitus	7.18e-05	0.000326	CcSEcCtD
Boceprevir—Constipation—Valsartan—type 2 diabetes mellitus	7.18e-05	0.000326	CcSEcCtD
Boceprevir—Infection—Irbesartan—type 2 diabetes mellitus	7.17e-05	0.000326	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.17e-05	0.000326	CcSEcCtD
Boceprevir—Fatigue—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000325	CcSEcCtD
Boceprevir—Hypotension—Metformin—type 2 diabetes mellitus	7.15e-05	0.000325	CcSEcCtD
Boceprevir—Malnutrition—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000324	CcSEcCtD
Boceprevir—Erythema—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000324	CcSEcCtD
Boceprevir—Shock—Irbesartan—type 2 diabetes mellitus	7.1e-05	0.000323	CcSEcCtD
Boceprevir—Pain—Orlistat—type 2 diabetes mellitus	7.1e-05	0.000323	CcSEcCtD
Boceprevir—Chest pain—Losartan—type 2 diabetes mellitus	7.09e-05	0.000322	CcSEcCtD
Boceprevir—Arthralgia—Losartan—type 2 diabetes mellitus	7.09e-05	0.000322	CcSEcCtD
Boceprevir—Myalgia—Losartan—type 2 diabetes mellitus	7.09e-05	0.000322	CcSEcCtD
Boceprevir—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.08e-05	0.000322	CcSEcCtD
Boceprevir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.08e-05	0.000322	CcSEcCtD
Boceprevir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	7.07e-05	0.000321	CcSEcCtD
Boceprevir—Anxiety—Losartan—type 2 diabetes mellitus	7.06e-05	0.000321	CcSEcCtD
Boceprevir—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.05e-05	0.00032	CcSEcCtD
Boceprevir—Rash—Bromocriptine—type 2 diabetes mellitus	7.02e-05	0.000319	CcSEcCtD
Boceprevir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.02e-05	0.000319	CcSEcCtD
Boceprevir—Skin disorder—Irbesartan—type 2 diabetes mellitus	7.01e-05	0.000319	CcSEcCtD
Boceprevir—Discomfort—Losartan—type 2 diabetes mellitus	7e-05	0.000318	CcSEcCtD
Boceprevir—Dysgeusia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.000318	CcSEcCtD
Boceprevir—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	6.98e-05	0.000317	CcSEcCtD
Boceprevir—Headache—Bromocriptine—type 2 diabetes mellitus	6.98e-05	0.000317	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.97e-05	0.000317	CcSEcCtD
Boceprevir—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.97e-05	0.000317	CcSEcCtD
Boceprevir—Dry mouth—Losartan—type 2 diabetes mellitus	6.93e-05	0.000315	CcSEcCtD
Boceprevir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	6.87e-05	0.000312	CcSEcCtD
Boceprevir—Paraesthesia—Metformin—type 2 diabetes mellitus	6.87e-05	0.000312	CcSEcCtD
Boceprevir—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000312	CcSEcCtD
Boceprevir—Confusional state—Losartan—type 2 diabetes mellitus	6.85e-05	0.000311	CcSEcCtD
Boceprevir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.84e-05	0.000311	CcSEcCtD
Boceprevir—Dyspnoea—Metformin—type 2 diabetes mellitus	6.82e-05	0.00031	CcSEcCtD
Boceprevir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	6.79e-05	0.000308	CcSEcCtD
Boceprevir—Infection—Losartan—type 2 diabetes mellitus	6.75e-05	0.000307	CcSEcCtD
Boceprevir—Hypotension—Irbesartan—type 2 diabetes mellitus	6.75e-05	0.000307	CcSEcCtD
Boceprevir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.74e-05	0.000306	CcSEcCtD
Boceprevir—Dyspepsia—Metformin—type 2 diabetes mellitus	6.73e-05	0.000306	CcSEcCtD
Boceprevir—Shock—Losartan—type 2 diabetes mellitus	6.68e-05	0.000304	CcSEcCtD
Boceprevir—Urticaria—Valsartan—type 2 diabetes mellitus	6.67e-05	0.000303	CcSEcCtD
Boceprevir—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.66e-05	0.000303	CcSEcCtD
Boceprevir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.65e-05	0.000302	CcSEcCtD
Boceprevir—Decreased appetite—Metformin—type 2 diabetes mellitus	6.65e-05	0.000302	CcSEcCtD
Boceprevir—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.64e-05	0.000302	CcSEcCtD
Boceprevir—Tachycardia—Losartan—type 2 diabetes mellitus	6.63e-05	0.000301	CcSEcCtD
Boceprevir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000301	CcSEcCtD
Boceprevir—Nausea—Bromocriptine—type 2 diabetes mellitus	6.62e-05	0.000301	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.6e-05	0.0003	CcSEcCtD
Boceprevir—Fatigue—Metformin—type 2 diabetes mellitus	6.59e-05	0.0003	CcSEcCtD
Boceprevir—Urticaria—Orlistat—type 2 diabetes mellitus	6.59e-05	0.0003	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.000299	CcSEcCtD
Boceprevir—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.57e-05	0.000299	CcSEcCtD
Boceprevir—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.56e-05	0.000298	CcSEcCtD
Boceprevir—Body temperature increased—Orlistat—type 2 diabetes mellitus	6.56e-05	0.000298	CcSEcCtD
Boceprevir—Asthenia—Gliclazide—type 2 diabetes mellitus	6.56e-05	0.000298	CcSEcCtD
Boceprevir—Agitation—Ramipril—type 2 diabetes mellitus	6.56e-05	0.000298	CcSEcCtD
Boceprevir—Constipation—Metformin—type 2 diabetes mellitus	6.54e-05	0.000297	CcSEcCtD
Boceprevir—Angioedema—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000296	CcSEcCtD
Boceprevir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.48e-05	0.000295	CcSEcCtD
Boceprevir—Vomiting—Glyburide—type 2 diabetes mellitus	6.47e-05	0.000294	CcSEcCtD
Boceprevir—Pruritus—Gliclazide—type 2 diabetes mellitus	6.47e-05	0.000294	CcSEcCtD
Boceprevir—Malaise—Ramipril—type 2 diabetes mellitus	6.44e-05	0.000293	CcSEcCtD
Boceprevir—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000293	CcSEcCtD
Boceprevir—Rash—Glyburide—type 2 diabetes mellitus	6.42e-05	0.000292	CcSEcCtD
Boceprevir—Dermatitis—Glyburide—type 2 diabetes mellitus	6.41e-05	0.000292	CcSEcCtD
Boceprevir—Vertigo—Ramipril—type 2 diabetes mellitus	6.41e-05	0.000291	CcSEcCtD
Boceprevir—Syncope—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000291	CcSEcCtD
Boceprevir—Leukopenia—Ramipril—type 2 diabetes mellitus	6.39e-05	0.00029	CcSEcCtD
Boceprevir—Headache—Glyburide—type 2 diabetes mellitus	6.38e-05	0.00029	CcSEcCtD
Boceprevir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.35e-05	0.000289	CcSEcCtD
Boceprevir—Hypotension—Losartan—type 2 diabetes mellitus	6.35e-05	0.000289	CcSEcCtD
Boceprevir—Palpitations—Ramipril—type 2 diabetes mellitus	6.31e-05	0.000287	CcSEcCtD
Boceprevir—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.3e-05	0.000287	CcSEcCtD
Boceprevir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	6.28e-05	0.000285	CcSEcCtD
Boceprevir—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.27e-05	0.000285	CcSEcCtD
Boceprevir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.26e-05	0.000284	CcSEcCtD
Boceprevir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.25e-05	0.000284	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000283	CcSEcCtD
Boceprevir—Cough—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000283	CcSEcCtD
Boceprevir—Fatigue—Irbesartan—type 2 diabetes mellitus	6.22e-05	0.000283	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.19e-05	0.000281	CcSEcCtD
Boceprevir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	6.19e-05	0.000281	CcSEcCtD
Boceprevir—Constipation—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000281	CcSEcCtD
Boceprevir—Pain—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000281	CcSEcCtD
Boceprevir—Insomnia—Losartan—type 2 diabetes mellitus	6.14e-05	0.000279	CcSEcCtD
Boceprevir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	6.12e-05	0.000278	CcSEcCtD
Boceprevir—Paraesthesia—Losartan—type 2 diabetes mellitus	6.1e-05	0.000277	CcSEcCtD
Boceprevir—Urticaria—Metformin—type 2 diabetes mellitus	6.08e-05	0.000276	CcSEcCtD
Boceprevir—Myalgia—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000276	CcSEcCtD
Boceprevir—Arthralgia—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000276	CcSEcCtD
Boceprevir—Chest pain—Ramipril—type 2 diabetes mellitus	6.08e-05	0.000276	CcSEcCtD
Boceprevir—Dyspnoea—Losartan—type 2 diabetes mellitus	6.06e-05	0.000275	CcSEcCtD
Boceprevir—Anxiety—Ramipril—type 2 diabetes mellitus	6.06e-05	0.000275	CcSEcCtD
Boceprevir—Nausea—Glyburide—type 2 diabetes mellitus	6.05e-05	0.000275	CcSEcCtD
Boceprevir—Abdominal pain—Metformin—type 2 diabetes mellitus	6.05e-05	0.000275	CcSEcCtD
Boceprevir—Dizziness—Gliclazide—type 2 diabetes mellitus	6.05e-05	0.000275	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	6.03e-05	0.000274	CcSEcCtD
Boceprevir—Asthenia—Valsartan—type 2 diabetes mellitus	6.03e-05	0.000274	CcSEcCtD
Boceprevir—Discomfort—Ramipril—type 2 diabetes mellitus	6e-05	0.000273	CcSEcCtD
Boceprevir—Dyspepsia—Losartan—type 2 diabetes mellitus	5.98e-05	0.000272	CcSEcCtD
Boceprevir—Asthenia—Orlistat—type 2 diabetes mellitus	5.96e-05	0.000271	CcSEcCtD
Boceprevir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.95e-05	0.00027	CcSEcCtD
Boceprevir—Pruritus—Valsartan—type 2 diabetes mellitus	5.94e-05	0.00027	CcSEcCtD
Boceprevir—Dry mouth—Ramipril—type 2 diabetes mellitus	5.94e-05	0.00027	CcSEcCtD
Boceprevir—Decreased appetite—Losartan—type 2 diabetes mellitus	5.91e-05	0.000268	CcSEcCtD
Boceprevir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000268	CcSEcCtD
Boceprevir—Confusional state—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000267	CcSEcCtD
Boceprevir—Pruritus—Orlistat—type 2 diabetes mellitus	5.87e-05	0.000267	CcSEcCtD
Boceprevir—Fatigue—Losartan—type 2 diabetes mellitus	5.86e-05	0.000266	CcSEcCtD
Boceprevir—Vomiting—Gliclazide—type 2 diabetes mellitus	5.81e-05	0.000264	CcSEcCtD
Boceprevir—Constipation—Losartan—type 2 diabetes mellitus	5.81e-05	0.000264	CcSEcCtD
Boceprevir—Pain—Losartan—type 2 diabetes mellitus	5.81e-05	0.000264	CcSEcCtD
Boceprevir—Rash—Gliclazide—type 2 diabetes mellitus	5.76e-05	0.000262	CcSEcCtD
Boceprevir—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.76e-05	0.000262	CcSEcCtD
Boceprevir—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.75e-05	0.000261	CcSEcCtD
Boceprevir—Urticaria—Irbesartan—type 2 diabetes mellitus	5.73e-05	0.000261	CcSEcCtD
Boceprevir—Shock—Ramipril—type 2 diabetes mellitus	5.73e-05	0.00026	CcSEcCtD
Boceprevir—Headache—Gliclazide—type 2 diabetes mellitus	5.73e-05	0.00026	CcSEcCtD
Boceprevir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.71e-05	0.00026	CcSEcCtD
Boceprevir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000259	CcSEcCtD
Boceprevir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.71e-05	0.000259	CcSEcCtD
Boceprevir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000259	CcSEcCtD
Boceprevir—Tachycardia—Ramipril—type 2 diabetes mellitus	5.69e-05	0.000258	CcSEcCtD
Boceprevir—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.68e-05	0.000258	CcSEcCtD
Boceprevir—Skin disorder—Ramipril—type 2 diabetes mellitus	5.66e-05	0.000257	CcSEcCtD
Boceprevir—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000256	CcSEcCtD
Boceprevir—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.6e-05	0.000254	CcSEcCtD
Boceprevir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.56e-05	0.000252	CcSEcCtD
Boceprevir—Dizziness—Valsartan—type 2 diabetes mellitus	5.55e-05	0.000252	CcSEcCtD
Boceprevir—Dizziness—Orlistat—type 2 diabetes mellitus	5.49e-05	0.000249	CcSEcCtD
Boceprevir—Asthenia—Metformin—type 2 diabetes mellitus	5.49e-05	0.000249	CcSEcCtD
Boceprevir—Hypotension—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000247	CcSEcCtD
Boceprevir—Nausea—Gliclazide—type 2 diabetes mellitus	5.43e-05	0.000247	CcSEcCtD
Boceprevir—Pruritus—Metformin—type 2 diabetes mellitus	5.41e-05	0.000246	CcSEcCtD
Boceprevir—Urticaria—Losartan—type 2 diabetes mellitus	5.4e-05	0.000245	CcSEcCtD
Boceprevir—Abdominal pain—Losartan—type 2 diabetes mellitus	5.37e-05	0.000244	CcSEcCtD
Boceprevir—Body temperature increased—Losartan—type 2 diabetes mellitus	5.37e-05	0.000244	CcSEcCtD
Boceprevir—Vomiting—Valsartan—type 2 diabetes mellitus	5.34e-05	0.000243	CcSEcCtD
Boceprevir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	5.32e-05	0.000242	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000241	CcSEcCtD
Boceprevir—Rash—Valsartan—type 2 diabetes mellitus	5.3e-05	0.000241	CcSEcCtD
Boceprevir—Dermatitis—Valsartan—type 2 diabetes mellitus	5.29e-05	0.000241	CcSEcCtD
Boceprevir—Vomiting—Orlistat—type 2 diabetes mellitus	5.28e-05	0.00024	CcSEcCtD
Boceprevir—Insomnia—Ramipril—type 2 diabetes mellitus	5.27e-05	0.000239	CcSEcCtD
Boceprevir—Headache—Valsartan—type 2 diabetes mellitus	5.26e-05	0.000239	CcSEcCtD
Boceprevir—Diarrhoea—Metformin—type 2 diabetes mellitus	5.23e-05	0.000238	CcSEcCtD
Boceprevir—Rash—Orlistat—type 2 diabetes mellitus	5.23e-05	0.000238	CcSEcCtD
Boceprevir—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000238	CcSEcCtD
Boceprevir—Dermatitis—Orlistat—type 2 diabetes mellitus	5.23e-05	0.000238	CcSEcCtD
Boceprevir—Headache—Orlistat—type 2 diabetes mellitus	5.2e-05	0.000236	CcSEcCtD
Boceprevir—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000236	CcSEcCtD
Boceprevir—Asthenia—Irbesartan—type 2 diabetes mellitus	5.18e-05	0.000235	CcSEcCtD
Boceprevir—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.13e-05	0.000233	CcSEcCtD
Boceprevir—Pruritus—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.000232	CcSEcCtD
Boceprevir—Decreased appetite—Ramipril—type 2 diabetes mellitus	5.06e-05	0.00023	CcSEcCtD
Boceprevir—Dizziness—Metformin—type 2 diabetes mellitus	5.06e-05	0.00023	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.03e-05	0.000229	CcSEcCtD
Boceprevir—Fatigue—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000228	CcSEcCtD
Boceprevir—Hypersensitivity—Losartan—type 2 diabetes mellitus	5.01e-05	0.000227	CcSEcCtD
Boceprevir—Nausea—Valsartan—type 2 diabetes mellitus	4.99e-05	0.000227	CcSEcCtD
Boceprevir—Constipation—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000226	CcSEcCtD
Boceprevir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.94e-05	0.000224	CcSEcCtD
Boceprevir—Nausea—Orlistat—type 2 diabetes mellitus	4.93e-05	0.000224	CcSEcCtD
Boceprevir—Asthenia—Losartan—type 2 diabetes mellitus	4.87e-05	0.000222	CcSEcCtD
Boceprevir—Vomiting—Metformin—type 2 diabetes mellitus	4.86e-05	0.000221	CcSEcCtD
Boceprevir—Rash—Metformin—type 2 diabetes mellitus	4.82e-05	0.000219	CcSEcCtD
Boceprevir—Dermatitis—Metformin—type 2 diabetes mellitus	4.82e-05	0.000219	CcSEcCtD
Boceprevir—Pruritus—Losartan—type 2 diabetes mellitus	4.81e-05	0.000218	CcSEcCtD
Boceprevir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.8e-05	0.000218	CcSEcCtD
Boceprevir—Headache—Metformin—type 2 diabetes mellitus	4.79e-05	0.000218	CcSEcCtD
Boceprevir—Dizziness—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000217	CcSEcCtD
Boceprevir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000217	CcSEcCtD
Boceprevir—Diarrhoea—Losartan—type 2 diabetes mellitus	4.65e-05	0.000211	CcSEcCtD
Boceprevir—Urticaria—Ramipril—type 2 diabetes mellitus	4.63e-05	0.00021	CcSEcCtD
Boceprevir—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000209	CcSEcCtD
Boceprevir—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.6e-05	0.000209	CcSEcCtD
Boceprevir—Vomiting—Irbesartan—type 2 diabetes mellitus	4.59e-05	0.000209	CcSEcCtD
Boceprevir—Rash—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000207	CcSEcCtD
Boceprevir—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000207	CcSEcCtD
Boceprevir—Nausea—Metformin—type 2 diabetes mellitus	4.54e-05	0.000207	CcSEcCtD
Boceprevir—Headache—Irbesartan—type 2 diabetes mellitus	4.52e-05	0.000206	CcSEcCtD
Boceprevir—Dizziness—Losartan—type 2 diabetes mellitus	4.49e-05	0.000204	CcSEcCtD
Boceprevir—Vomiting—Losartan—type 2 diabetes mellitus	4.32e-05	0.000196	CcSEcCtD
Boceprevir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000195	CcSEcCtD
Boceprevir—Nausea—Irbesartan—type 2 diabetes mellitus	4.29e-05	0.000195	CcSEcCtD
Boceprevir—Rash—Losartan—type 2 diabetes mellitus	4.28e-05	0.000195	CcSEcCtD
Boceprevir—Dermatitis—Losartan—type 2 diabetes mellitus	4.28e-05	0.000195	CcSEcCtD
Boceprevir—Headache—Losartan—type 2 diabetes mellitus	4.26e-05	0.000193	CcSEcCtD
Boceprevir—Asthenia—Ramipril—type 2 diabetes mellitus	4.18e-05	0.00019	CcSEcCtD
Boceprevir—Pruritus—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000187	CcSEcCtD
Boceprevir—Nausea—Losartan—type 2 diabetes mellitus	4.04e-05	0.000183	CcSEcCtD
Boceprevir—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.99e-05	0.000181	CcSEcCtD
Boceprevir—Dizziness—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000175	CcSEcCtD
Boceprevir—Vomiting—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000168	CcSEcCtD
Boceprevir—Rash—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000167	CcSEcCtD
Boceprevir—Dermatitis—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000167	CcSEcCtD
Boceprevir—Headache—Ramipril—type 2 diabetes mellitus	3.65e-05	0.000166	CcSEcCtD
Boceprevir—Nausea—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000157	CcSEcCtD
Boceprevir—CYP3A5—Metabolism—SLC5A2—type 2 diabetes mellitus	1.27e-05	9.77e-05	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—type 2 diabetes mellitus	1.26e-05	9.74e-05	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—type 2 diabetes mellitus	1.26e-05	9.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	1.26e-05	9.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	1.26e-05	9.73e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NCOA6—type 2 diabetes mellitus	1.24e-05	9.6e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	1.24e-05	9.54e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—UCP3—type 2 diabetes mellitus	1.22e-05	9.43e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—UCP2—type 2 diabetes mellitus	1.22e-05	9.43e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HSD11B1—type 2 diabetes mellitus	1.22e-05	9.43e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.22e-05	9.42e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.22e-05	9.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.22e-05	9.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.22e-05	9.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.22e-05	9.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.22e-05	9.39e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—EGFR—type 2 diabetes mellitus	1.21e-05	9.37e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.19e-05	9.18e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.18e-05	9.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.17e-05	9.06e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PCK1—type 2 diabetes mellitus	1.15e-05	8.87e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—type 2 diabetes mellitus	1.13e-05	8.75e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.13e-05	8.73e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.11e-05	8.59e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.11e-05	8.59e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.09e-05	8.42e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.09e-05	8.41e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.08e-05	8.37e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.08e-05	8.33e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HK1—type 2 diabetes mellitus	1.08e-05	8.31e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.07e-05	8.26e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.06e-05	8.21e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—type 2 diabetes mellitus	1.05e-05	8.07e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HSD3B2—type 2 diabetes mellitus	1.04e-05	8.02e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—KCNJ11—type 2 diabetes mellitus	1.04e-05	8.02e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCKR—type 2 diabetes mellitus	1.04e-05	8.02e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPA—type 2 diabetes mellitus	1.04e-05	8.02e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.04e-05	7.99e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.04e-05	7.99e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.04e-05	7.99e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.03e-05	7.98e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.02e-05	7.87e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALDOB—type 2 diabetes mellitus	9.97e-06	7.69e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	9.92e-06	7.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	9.92e-06	7.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	9.55e-06	7.37e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	9.55e-06	7.37e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	9.5e-06	7.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	9.38e-06	7.24e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—type 2 diabetes mellitus	9.34e-06	7.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	9.3e-06	7.18e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	9.3e-06	7.18e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	9.27e-06	7.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	9.25e-06	7.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	9.23e-06	7.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	9.23e-06	7.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	9.23e-06	7.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	8.92e-06	6.88e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	8.88e-06	6.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	8.82e-06	6.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	8.82e-06	6.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	8.8e-06	6.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	8.67e-06	6.69e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	8.65e-06	6.67e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—type 2 diabetes mellitus	8.61e-06	6.65e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	8.5e-06	6.56e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	8.49e-06	6.55e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	8.47e-06	6.54e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	8.47e-06	6.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	8.41e-06	6.49e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	8.33e-06	6.42e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	8.31e-06	6.41e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	8.26e-06	6.37e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	8.26e-06	6.37e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	8.26e-06	6.37e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—type 2 diabetes mellitus	8.22e-06	6.35e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	8.21e-06	6.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	8.12e-06	6.27e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	8.06e-06	6.22e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	7.97e-06	6.15e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	7.95e-06	6.13e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	7.93e-06	6.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	7.84e-06	6.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	7.84e-06	6.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	7.84e-06	6.05e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	7.84e-06	6.05e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	7.77e-06	5.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	7.77e-06	5.99e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.59e-06	5.85e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	7.52e-06	5.8e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.5e-06	5.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.5e-06	5.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.5e-06	5.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.5e-06	5.79e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.5e-06	5.79e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	7.41e-06	5.72e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	7.41e-06	5.72e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	7.41e-06	5.72e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	7.27e-06	5.61e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.26e-06	5.6e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	7.21e-06	5.56e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.17e-06	5.53e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	7.05e-06	5.44e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	6.99e-06	5.39e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	6.86e-06	5.29e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	6.86e-06	5.29e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	6.77e-06	5.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.73e-06	5.19e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	6.7e-06	5.17e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	6.7e-06	5.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	6.68e-06	5.16e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	6.53e-06	5.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.53e-06	5.04e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	6.42e-06	4.96e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	6.42e-06	4.96e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	6.39e-06	4.93e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	6.39e-06	4.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.38e-06	4.92e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.38e-06	4.92e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.38e-06	4.92e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	6.27e-06	4.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	6.23e-06	4.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	6.23e-06	4.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	6.23e-06	4.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.19e-06	4.78e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.11e-06	4.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.11e-06	4.72e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.08e-06	4.69e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	6.01e-06	4.64e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	5.9e-06	4.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	5.89e-06	4.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	5.89e-06	4.54e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	5.78e-06	4.46e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	5.68e-06	4.39e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	5.68e-06	4.39e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	5.68e-06	4.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.59e-06	4.31e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.59e-06	4.31e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.59e-06	4.31e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.54e-06	4.27e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.54e-06	4.27e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.51e-06	4.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.49e-06	4.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.44e-06	4.2e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	5.44e-06	4.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.34e-06	4.12e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.33e-06	4.11e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.32e-06	4.11e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5.28e-06	4.07e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.13e-06	3.96e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.11e-06	3.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.05e-06	3.9e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.05e-06	3.9e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.04e-06	3.89e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5e-06	3.86e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	4.93e-06	3.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	4.93e-06	3.8e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	4.92e-06	3.79e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	4.85e-06	3.74e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	4.85e-06	3.74e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.83e-06	3.73e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.83e-06	3.73e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.83e-06	3.73e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.83e-06	3.73e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	4.79e-06	3.69e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	4.73e-06	3.65e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.63e-06	3.58e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.54e-06	3.5e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.45e-06	3.43e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.31e-06	3.33e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.31e-06	3.32e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.24e-06	3.27e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.22e-06	3.26e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.18e-06	3.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.18e-06	3.22e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.18e-06	3.22e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.16e-06	3.21e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.1e-06	3.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.02e-06	3.1e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	3.98e-06	3.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.94e-06	3.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.94e-06	3.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.87e-06	2.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.86e-06	2.98e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.84e-06	2.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.84e-06	2.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.84e-06	2.96e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.82e-06	2.94e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.8e-06	2.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.75e-06	2.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.72e-06	2.87e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.71e-06	2.86e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.7e-06	2.86e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.68e-06	2.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.61e-06	2.79e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.61e-06	2.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.57e-06	2.75e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.44e-06	2.66e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.44e-06	2.66e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.44e-06	2.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.42e-06	2.64e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.38e-06	2.61e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.36e-06	2.59e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.35e-06	2.58e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.31e-06	2.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.28e-06	2.53e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.25e-06	2.51e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.2e-06	2.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.19e-06	2.46e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.16e-06	2.44e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.16e-06	2.44e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.15e-06	2.43e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.15e-06	2.43e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.11e-06	2.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.11e-06	2.4e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.99e-06	2.3e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.99e-06	2.3e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	2.89e-06	2.23e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.78e-06	2.14e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.72e-06	2.1e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.57e-06	1.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.57e-06	1.99e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.56e-06	1.98e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.53e-06	1.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.5e-06	1.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.45e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.39e-06	1.84e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.39e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.39e-06	1.84e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.34e-06	1.81e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.29e-06	1.77e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.29e-06	1.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.23e-06	1.72e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.2e-06	1.7e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.18e-06	1.69e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.11e-06	1.63e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.07e-06	1.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2e-06	1.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.97e-06	1.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.96e-06	1.52e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.94e-06	1.5e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.71e-06	1.32e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.68e-06	1.29e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.54e-06	1.19e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.47e-06	1.14e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.47e-06	1.14e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.45e-06	1.12e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.35e-06	1.04e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.1e-06	8.47e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.76e-07	5.22e-06	CbGpPWpGaD
